Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 101 related to Andersen: Long-Term Renoprotective Effects of Losartan in Diabetic Nephropathy. (0.09 sec) 

Long-Term Renoprotective Effects of Losartan in Diabetic Nephropathy

- Free from Publisher
S Andersen, L Tarnow, F Cambien, P Rossing, … - Diabetes Care, 2003 - Am Diabetes Assoc
RESULTS—At baseline, GFR, albuminuria, and blood pressure were similar in the
two genotype groups, II versus DD: mean (SD), 86 (22) vs. 88 (24) ml · min –1
· 1.73 m –2 ; median (interquartile range), 1,134 (598–2,023) vs. ...
Cited by 39 - Related articles - BL Direct - All 5 versions

Renoprotective effects of losartan in diabetic nephropathy: Interaction with ACE insertion/ …


S Andersen, L Tarnow, F Cambien, P Rossing, … - Kidney international, 2002 - nature.com
The beneficial short- and long-term renoprotective effects of angiotensin
I-converting enzyme (ACE) inhibition are lower in albuminuric diabetic patients
homozygous for the deletion compared to the insertion polymorphism of the ...
Cited by 28 - Related articles - BL Direct - All 4 versions

Genetic variation in the renin-angiotensin system and progression of diabetic nephropathy

- asnjournals.org
P Jacobsen, L Tarnow, B Carstensen, P Hovind … - Journal of the American Society of Nephrology, 2003 - Am Soc Nephrol
Originally, we reported patients homozygous for the deletion (D) allele of a
polymorphism in the gene coding for angiotensin-converting enzyme (ACE/ID) to
have an accelerated loss of GFR during 7 yr of ACE inhibition (ACE-I) in 35 ...
Cited by 64 - Related articles - BL Direct - All 6 versions

ACE gene polymorphism and losartan treatment in type 2 diabetic patients with nephropathy

- nih.gov
HH Parving, D de Zeeuw, ME Cooper, G … - J Am Soc Nephrol, 2008 - Am Soc Nephrol
ABSTRACT Losartan treatment reduced renal outcomes in proteinuric patients with
type 2 diabetes in the Reduction of Endpoints in NIDDM with the Angiotensin II
Antagonist Losartan (RENAAL) study. It is unknown whether an insertion (I)/ ...
Cited by 13 - Related articles - All 6 versions

Optimal dose of losartan for renoprotection in diabetic nephropathy

- oxfordjournals.org
S Andersen, P Rossing, TR Juhl, J Deinum, … - Nephrology Dialysis Transplantation, 2002 - ERA-EDTA
Results. Baseline values of albuminuria (geometric mean (95% CI)) and GFR
(means±SEM) were 1138 (904–1432) mg/24 h and 91±3 ml/min/1.73 m 2 ,
respectively. The blood pressure at baseline was 155/81±3/2 mmHg. All ...
Cited by 56 - Related articles - BL Direct - All 4 versions

Angiotensin-converting enzyme (ACE) inhibition in type 2, diabetic patients–interaction …


WY So, RCW Ma, R Ozaki, PCY Tong, MCY … - Kidney International, 2006 - nature.com
Angiotensin-converting enzyme (ACE) insertion(I)/deletion (D) polymorphism may
modify the effect of inhibition of the renin–angiotensin–aldosterone system
(RAAS) on survival and cardiorenal outcomes in type 2, diabetes. A ...
Cited by 25 - Related articles - BL Direct - All 5 versions

Antiproteinuric effect of losartan in non-diabetic renal disease is not dependent on ACE …


HCPHY Choi, BSKSW Kang, KHCSK Ha, … - Kidney Blood Press Res, 2006 - content.karger.com
Page 1. Fax +41 61 306 12 34 E-Mail karger@karger.ch www.karger.com Original Paper
Kidney Blood Press Res 2006;29:216–224 DOI: 10.1159/000095736 ...
Cited by 4 - Related articles - BL Direct - All 5 versions

Effect of deletion polymorphism of angiotensin converting enzyme gene on progression of …

- bmj.com
HH Parving, P Jacobsen, L Tarnow, P Rossing, … - British Medical Journal, 1996 - bmj.com
We examined the records of all patients with albuminuria attending the
outpatient clinic at Steno Diabetes Centre in 1993 who had insulin dependent
diabetes mellitus and diabetic nephropathy 13 and had had their glomerular ...
Cited by 159 - Related articles - BL Direct - All 5 versions

Angiotensin converting enzyme gene polymorphism and ACE inhibition in diabetic …


P Jacobsen, K Rossing, P Rossing, L Tarnow, … - Kidney international, 1998 - nature.com
Received 2 May 1997; Revised 6 November 1997; Accepted 7 November 1997. ...
Angiotensin converting enzyme gene polymorphism and ACE inhibition in diabetic
nephropathy. The antiproteinuric effect of angiotensin converting enzyme ...
Cited by 94 - Related articles - BL Direct - All 3 versions

Preventing end stage renal disease in diabetic patients--genetic aspect (part I)


PK Jacobsen - Journal of Renin-Angiotensin-Aldosterone System, 2005 - jra.sagepub.com
DOI: 10.3317/jraas.2005.001 2005; 6; 1 J Renin Angiotensin Aldosterone Syst
Peter Karl Jacobsen Preventing end stage renal disease in diabetic patients
genetic aspect (part I) ... Journal of Renin-Angiotensin-Aldosterone ...
Cited by 17 - Related articles - All 9 versions


Result Page: 

1

2

3

4

5

6

7

8

9

10

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google